Search Orphan Drug Designations and Approvals
-
Generic Name: | humanized single chain monoclonal antibody(scFV: IgG1 hinge: IgG1 CH2 and CH3 domains) |
---|---|
Date Designated: | 11/17/2011 |
Orphan Designation: | Treatment of chronic lymphocytic leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Aptevo Therapeutics, Inc. 2401 Fourth Avenue Suite 1050 Seattle, Washington 98121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-